Evidence map›Paper›PMID 25919649›Full record

ReviewTransboundary and emerging diseases2017

Hepatitis E Virus and Related Viruses in Animals.

D Thiry, A Mauroy, N Pavio, M A Purdy, N Rose, E Thiry, E F de Oliveira-Filho

Open access · bronzeAbstract readReview
In one paragraph

Review in Transboundary and emerging diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Nationwide survey of hepatitis E virus infection among wildlife in Japan.The Journal of veterinary medical science · 2022
    Article
  10. Article
  11. Article
  12. Seroprevalence of hepatitis E virus among blood donors on Corsica, France, 2017.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2020
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. ORF3 as a sensitive and specific diagnostic index for hepatitis E.Experimental and therapeutic medicine · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

D ThiryVeterinary Virology and Animal Viral Diseases, Department of Infectious and Parasitic Diseases, FARAH, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium.
A MauroyVeterinary Virology and Animal Viral Diseases, Department of Infectious and Parasitic Diseases, FARAH, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium.
N PavioUMR 1161 Virology, ANSES, Animal Health Laboratory, Maisons-Alfort, France.
M A PurdyNational Center for HIV/Hepatitis/STD/TB Prevention, Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA.
N RoseANSES Laboratory of Ploufragan/Plouzané, Unit of Pig Epidemiology and Welfare, Ploufragan, France.
E ThiryVeterinary Virology and Animal Viral Diseases, Department of Infectious and Parasitic Diseases, FARAH, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium.
E F de Oliveira-FilhoVeterinary Virology and Animal Viral Diseases, Department of Infectious and Parasitic Diseases, FARAH, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium.
University of Liège · BEAgence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail · FRAgence Nationale des Fréquences · FRCenters for Disease Control and Prevention · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis E is an acute human liver disease in healthy individuals which may eventually become chronic. It is caused by the hepatitis E virus (HEV) and can have a zoonotic origin. Nearly 57,000 people die yearly from hepatitis E-related conditions. The disease is endemic in both developing and developed countries with distinct epidemiologic profiles. In developing countries, the disease is associated with inadequate water treatment, while in developed countries, transmission is associated with animal contact and the ingestion of raw or uncooked meat, especially liver. All human HEV are grouped into at least four genotypes, while HEV or HEV-related viruses have been identified in an increasing number of domestic and wild animal species. Despite a high genetic diversity, only one single HEV serotype has been described to date for HEV genotypes 1-4. The discovery of new HEV or HEV-related viruses leads to a continuing increase in the number of genotypes. In addition, the genome organization of all these viruses is variable with overlapping open reading frames (ORF) and differences in the location of ORF3. In spite of the role of some domestic and wild animals as reservoir, the origin of HEV and HEV-related viruses in humans and animals is still unclear. This review discusses aspects of the detection, molecular virology, zoonotic transmission and origin of HEV and HEV-related viruses in the context of 'One Health' and establishes a link between the previous and the new taxonomy of this growing virus family.

Indexed as

AnimalsDisease ReservoirsGenotypeHepatitis EHepatitis E virusHumansZoonoseshepatitis E virusinfected speciesnew taxonomyoriginzoonosis

Identifiers

PMID25919649
PMCPMC7169709
OpenAlexW1967589537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.